FDA Drama & Psychedelic Setback — This Week in Biotech #58

from Biotech Blueprint · host Katerina Roznik

Subscribe for FREE HERE.FDA turmoil impacts key drug decisions, Compass’s phase 3 psilocybin data spooks investors, and Exelixis soars on cancer results (June 20–26, 2025).

Episode metadata supplied by the publisher feed · Published Jun 27, 2025

Embed this episode

Attribution link and audio player

Ready to play

FDA Drama & Psychedelic Setback — This Week in Biotech #58

0:00 8:30

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Biotech Blueprint?

This episode is 8 minutes long.

When was this Biotech Blueprint episode published?

This episode was published on June 27, 2025.

Can I download this Biotech Blueprint episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!